Severe leukopenia associated with mild hepatotoxicity in an HIV carrier treated with nevirapine

Japanese Journal of Infectious Diseases

Volumn 57, Issue 5, 2004, Pages 212-213

  Shahar, Eduardo ^a,b   Krivoy, Norberto ^a,b   Weltfriend, Sara ^b   Pollack, Shimon ^a,b  

^a RAMBAM MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPRURITIC AGENT; GENTAMICIN; INDINAVIR; LAMIVUDINE; NEVIRAPINE; PIPERACILLIN PLUS TAZOBACTAM; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; ZIDOVUDINE;

ADULT; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG ERUPTION; DRUG SURVEILLANCE PROGRAM; DRUG WITHDRAWAL; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INFECTION PREVENTION; LEUKOPENIA; LIPODYSTROPHY; LIVER TOXICITY; RASH; SKIN MANIFESTATION;

ADULT; ANTI-HIV AGENTS; FEMALE; HIV INFECTIONS; HUMANS; LEUKOPENIA; LIVER DISEASES; NEVIRAPINE;

EID: 9144230113     PISSN: 13446304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Carpenter, C. C. J., Cooper, D. A. and Fischl, M. A. (2000): Antiretroviral therapy in adults. Updated recommendations of the International AIDS Society-USA Panel. JAMA, 283, 381-390.
2. Centers for Disease Control and Prevention (2001): Serious adverse events attributed to nevirapine regiments for postexposure prophylaxis after HIV exposures-worldwide, 1997-2000. Morbid. Wkly. Rep.,49, 1153-1156.
3. González de Requena, D., Núñez, M. and Jiménez-Nácher, I. (2002): Liver toxicity caused by nevirapine. AIDS, 16, 290-291.
4. Piliero, P.J. and Purdy, B. (2001): Nevirapine-induced hepatitis: a case series and review of the literature. AIDS Read, 11, 379-382.
5. Das, S., Allan, P. S. and Wade, A. A. H. (2001): Adverse effects of nevirapine. Letter. Lancet, 358, 506.
6. Yamamoto, Y., Yasuoka, A., Yasuoka, C., Genka, I., Teruya, K., Kikuchi, Y., Tachikawa, N. and Oka, S. (2000): Leukocytopenia due to zidovudine- and nevirapine-containing regimens in elderly patients with HIV infection. Jpn. J. Infect. Dis., 53, 244-245.